FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079692 [Registered on: 29/01/2025] Trial Registered Prospectively
Last Modified On: 06/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Role of Godugdha Vaitarana basti in Gridhrasi 
Scientific Title of Study   Analytical clinical study of Godugdha Vatarana basti in different stages of Gridhrasi 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shruti Chaurasia 
Designation  MD SCHOLAR 
Affiliation  Himalayiya ayurvedic pg medical college and Hospital 
Address  OPD NO 11,Department of Panchkarma, Himalayiya ayurvedic pg medical college and Hospital, Fatehpur tanda, Majri grant via Doiwala, Dehradun uttaranchal

Dehradun
UTTARANCHAL
248140
India 
Phone  9105789335  
Fax    
Email  cshruti913@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shrimant Gangaram Chavan 
Designation  ASSOCIATE PROFESSOR 
Affiliation  Himalayiya Ayurvedic PG Medical College and Hospital 
Address  OPD NO 11,Department of Panchkarma, Himalayiya Ayurvedic PG Medical College and Hospital, Fatehpur tanda, Majri grant via Doiwala, Dehradun Uttaranchal

Dehradun
UTTARANCHAL
248140
India 
Phone  9916863633  
Fax    
Email  drshrimantgc.bc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shruti Chaurasia 
Designation  MD SCHOLAR 
Affiliation  Himalayiya Ayurvedic PG Medical College and Hospital 
Address  OPD NO 11,Department of Panchkarma, Himalayiya Ayurvedic PG Medical College and Hospital, Fatehpur tanda, Majri grant via Doiwala, Dehradun uttaranchal

Dehradun
UTTARANCHAL
248140
India 
Phone  9105789335  
Fax    
Email  cshruti913@gmail.com  
 
Source of Monetary or Material Support  
Himalayiya ayurvedic pg medical college and hospital fatehpur tanda majri grant via doiwala dehradun 248140, Uttaranchal, India 
 
Primary Sponsor  
Name  Himalayiya Ayurvedic PG Medical College and Hospital 
Address  Department of panchakarma Himalayiya Ayurvedic PG Medical College and Hospital Fatehpur Tanda Majri Grant via Doiwala Dehradun Uttaranchal 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHRUTI CHAURASIA  Himalayiya ayurvedic pg medical college and Hospital  OPD NO 11,Department of Panchkarma, Himalayiya ayurvedic pg medical college and Hospital, Fatehpur tanda, Majri grant via Doiwala, Dehradun uttaranchal
Dehradun
UTTARANCHAL 
9105789335

cshruti913@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: ChakraduttaNiruhadhikara 73/32, Procedure details: Vaitarana Basti (made with Godugdha) will be given for 15 days)
(1) Medicine Name: Godugdha Vaitarana Basti, Reference: ChakraduttaNiruhadhikara 73/32, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 380(ml), Frequency: od, Duration: 15 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Presence of ruk, tod, stambha and spandana in the sphik, kati, uru, janu, jangha and pada.
2. Tenderness along the course of sciatic nerve.
3. patients between age group of 20 to 60 years. 
 
ExclusionCriteria 
Details  1. Uncontrolled diabetes mellitus and cardiovascular diseases.
2. Pregnant and lactating mother
3. Tuberculosis of vertebral column
4. Tumour of cauda equina and lumbosacral plexus. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in Cardinal Sign and Symptoms of the Gridhrasi  Before Treatment, After Treatment and After Follow up 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Quality of Life of Patients of Gridhrasi  Before Treatment, After Treatment & After Follow up 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   N/A 
Date of First Enrollment (India)   08/02/2025 
Date of Study Completion (India) 06/09/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 06/09/2025 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
A Critical Review On Vaitarana Basti In Gridhrasi With Special Reference To Sciatica  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

MATERIAL AND METHODS:

          All the classical texts will be well churned to establish the facts about VaitaranaBasti and its application in Gridhrasi. This is a single blind clinical trial. The main object of the present work is to undertake a clinical study of Vaitarana Basti in the management of Gridhrasi.

Selection of the Cases

For this clinical study, patient of age group 20 year to 60 years will be randomly selected for the study. The cases will be registered on the clinical basis and investigation from OPD and IPD of Himalayiya Ayurvedic (P.G.) Medical College and Hospital, Dehradun, U.K. Cases will be selected randomly for this clinical study irrespective of Religion, Occupation, Sex etc.

INCLUSION CRITERIA

Criteria for diagnosis will be done on the basis of sign and symptoms available in the Ayurvedic and Modern texts as well as with the help of following parameters.

·       Patient fit for Vaitaranabasti

·       Presence of Ruk, Toda, Stambha and Spandana in the Sphik, Kati, Uru, Janu,Jangha and Pada.

·       Tenderness along the course of sciatic nerve

·       Patients between age group of 20 to 60 years were including.

Exclusion Criteria

·       Patient unfit for vaitaranabasti

·       Tumour of cauda equina and lumbosacral plexus

·       Uncontrolled Diabetes mellitus

·       Cardiovascular disease

·       Pregnanant and lactating mother

·       Tuberculosis of Vertebral column

Diagnostic criteria

·       Rukh (Pain)

·       Toda (Pricking)

·       Stambha (Stiffness) and

·       Spandana (Ttiching) in the ( Sphik, Kati, Uru, Janu, Jangha and Pada)

·       Gaurava (Heaviness)

·        S.L.R. test

·       Popliteal compression test

·       Knee-jerks and ankle-jerks.

Investigation

·       CBS, ESR

·       RBS

·       Lipid Profile

·       LFT

·       KFT

·       Routine and microscopic examination of urine and stool

·       X-ray of Lumbosacral region (Anterio Posterior & Lateral view)

 

 

 

 

AssessmentCriteria                                         

The improvement in the patients will be assessed mainly on the basis of relief in the cardinal symptoms of the disease. To assess the effect of therapy objectively, all the sign and symptoms will be given scoring pattern dependingupon their severity as below:

Rukh (Pain)

·       No pain - 0

·       Occasional pain - 1

·       Mild pain but no difficulty inwalking- 2

·       Moderate pain and slightdifficulty in walking- 3

·       Severe pain with severe difficultyin walking- 4

Toda (Pricking Sensation)

·       No pricking sensation - 0

·       Occasionally pricking sensation - 1

·       Mild pricking sensation - 2

·       Moderate pricking sensation - 3

·       Severe pricking sensation - 4

Stambha (Stiffness)

·       No stiffness - 0

·       Sometimes for 5 – 10 minutes - 1

·       Daily for 10 – 30 minutes – 2

·       Daily for 30 – 60 minutes - 3

·       Daily more than 1 hour - 4

Spandana (Twitching)

·       No Twitching - 0

·       Sometimes for 5-10 minutes - 1

·       Daily for 10-30 minutes - 2

·       Daily for 30-60 minutes - 3

·       Daily more than 1 hour - 4

Gaurava (Heaviness)

·       No heaviness - 0

·       Mild heaviness - 1

·       Moderate heaviness - 2

·       Severe heaviness - 3

S.L.R. Test

·       More than 90° - 0

·       71° – 90° - 1

·       51° – 70° - 2

·       31° – 50° - 3

·       Up to 30° - 4

 

Other symptoms

·       Symptom present – 2

·       Markedly reduced - 1

·       Absent - 0

·       No remarkable improvement - 2

 

STATISTICAL ANALYSIS

CRITERIA FOR ASSESSING THE TOTAL EFFECT

Considering the overall improvement will be shown by the patient in sign and symptoms, the total effect of thetherapywill have been assessed as below.

1. Complete remission: - > 75% relief in signs and symptoms

2. Marked Improvement: - 51% to 75% relief in signs and symptoms

3. Moderate Improvement: - 25 to 50% relief in signs and symptoms

4. Unchanged: - Below 25% relief in signs and symptoms

Sample Size

            As per sample size calculated: Formula,                               

 

                                                     n =

Z2 P (1-P)

d2

Where, P = Prevalence rate of Amavata which is 0.75%

                    d = Margin of error generally taken is 0.05%

                    Z = Z Score = 1.96

            By above calculation, n = 288.12

            Due to limitation of time and other resources, we will take 50 patients for the present study which will be randomly selected for a group.

Method of Data Collection:

            After the completion of treatment, the assessment will be done on same criteria as before the treatment and scoring will be done on the same pattern. The different tables of scores, obtained before treatment and after treatment, will be prepared for the comparison and statistical analysis will be done.

Type of Study:Randomized Clinical Trial

Level of Study:OPD and IPD Level

Period of Study: 1 1/2 Months

Duration of Treatment:15 days

·       There will be 2 sittings.

·       8 days Basti and 8 days’ Rest.

Method of Treatment:

The patients will be randomly divided into two groups.

·       VaitaranaBasti with Godugdha(Treatment Group): The patients of this group will be given VaitaranaBasti in the format of KaalBasti for four weeks.

Method of Intervention:

Intervention Name

Group A

Selected Drugs

ForSnehana – TilTaila

For Swedana – NadiSweda with DashmoolaKwath

SaindhavaLavana (Rock Salt)

TilaTaila (Sesame Oil)

Guda(Jaggery)

Godugdha (Milk of Cow)

Chincha (Amlika)

Form of Medicine

Vaitaranabasti

Composition of Medicine

All the components of VaitaranaBasti

Preparation of Medicine

According to the method mentioned in the book

Dose of Medicine

380ml

Route of Administration

Rectal Route

Procedure

Basti

Duration

15 days

Sittings

1 Sittings

(15 days Basticountinous)

 

Follow Up:

·       Follow up – After 15th day of treatment

7. OBSERVATION AND RESULT:

Observation

            Observation will be done on the basis of Subjective and objective parameters before and after completion of the treatment.

Statistical Analysis

             To obtain the efficacy of the therapy, proper statistical analysis will be carried out of available data.Mean, percentage, ±S.D., ±S.E., ‘t’ and P value were calculated. Paired ‘t’ test will be used for calculating the ‘t’value.

Result: The result will be analysed statistically and discussed.

 
Close